Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Mishra, K. V. R. Rao, R. N. Samal (Berhampur, Ganjam, Orissa, India). Montelukast: better option in childhood asthma and boon for associated tonsillitis. Eur Respir J 2007; 30: Suppl. 51, 2706

Member's Comments

Narayan Mishra - 09.12.2023 19:10
An interesting finding, to be further investigated.

Related content which might interest you: Bronchial thermoplasty: a new therapeutic option for the treatment of severe, uncontrolled asthma in adults Source: Eur Respir Rev 2014; 23: 510-518 Year: 2014 Montelukast in paediatric asthma: where we are now and what still needs to be done? Source: International Congress 2014 – Clinical Trial presentation and discussion "Cysteinyl leukotrienes and paediatric asthma: a new horizon or a blind alley?" Year: 2014 Montelukast in cases of severe asthma Source: Eur Respir J 2002; 20: Suppl. 38, 407s Year: 2002 Bronchial thermoplasty: an option for treating asthma? Source: Annual Congress 2012 - Endo meets obstruction: the new endoscopic treatment options for obstructive lung diseases Year: 2012 Asthma in pre-schoolers: difficult to treat Source: Annual Congress 2005 - Asthma in the preschool child Year: 2005 Only severe asthma? Source: International Congress 2019 – PG11 Severe paediatric asthma Year: 2019 Montelukast for toddler asthma? A meta-analysis of montelukast in preschool wheeze Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies Year: 2016 Difficult to treat asthma Source: Annual Congress 2006 - Clinical year in review Year: 2006 Could montelukast reduce asthma exacerbations? Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases Year: 2008 Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues Year: 2017 Acute severe asthma: evidence-based management of asthma exacerbations Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond Year: 2008 Montelukast causes additive benefit in acute asthma Source: Eur Respir J 2001; 18: Suppl. 33, 50s Year: 2001 Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013 The use of omalizumab in the management of severe chronic paediatric asthma Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008 Inhaled budesonide for the treatment of chronic wheezing in early childhood Source: Eur Respir J 2003; 22: Suppl. 45, 132s Year: 2003 Combination asthma medication and healthcare use in severe or difficult-to-treat asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004 Cost implications for the introduction of omalizumab in to the management of severe chronic asthma in children Source: Eur Respir J 2006; 28: Suppl. 50, 481s Year: 2006 Omalizumab is effective in patients with severe persistent allergic asthma in a real-life setting irrespective of age Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Budesonide/formoterol for maintenance and relief in adolescents with asthma: fewer exacerbations and improved asthma control Source: Eur Respir J 2004; 24: Suppl. 48, 164s Year: 2004